In a nutshell

Six things to know about us:

  • Single provider of flu vaccines for Brazil’s public immunization program: 60 million doses in 2018, full capacity up to 140 million doses/year
  • Manufactures 90% of all animal-derived immunoglobulins distributed in Brazil
  • Tetravalent dengue vaccine: Butantan-MSD agreement recently signed
  • Successful R&D collaborations with major players as GSK, MSD and Sanofi.
  • Intellectual property: over 50 patent families
  • Located in São Paulo, Brazil, where 78% of the Brazilian pharma sales occur